Department of Vascular and Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Sciences, Poznan, Poland.
Department of General and Vascular Surgery, Poznan University of Medical Sciences, ul. Długa ½, 60-848, Poznan, Poland.
Abdom Radiol (NY). 2018 Dec;43(12):3479-3486. doi: 10.1007/s00261-018-1633-x.
The aim of the study was to assess the effectiveness of Superb Micro-vascular Imaging (SMI) as an alternative to Contrast-Enhanced Ultrasound (CEUS) and Computed Tomography Angiography (CTA) for endoleak detection and classification in patients followed up after endovascular abdominal aortic aneurysm repair (EVAR).
From May 2015 to January 2017, 30 patients underwent post-EVAR follow-up with Color Doppler Ultrasound (CDUS), CEUS, SMI, and CTA examinations. Aneurysmal sac diameter and graft patency were evaluated; endoleaks were identified and classified. Sensitivity, specificity, and accuracy values were calculated for each of the four diagnostic methods of endoleak detection. A percentage of agreement and Cohen's Kappa coefficient were calculated for comparison of methods in terms of endoleak identification.
CTA revealed fifteen endoleaks (50%): three type Ia, nine type II, and three type III. The sensitivity of CDUS, CEUS, and SMI relative to CTA was 27%, 100%, and 100%, respectively. Specificity was 93%, 93%, and 93%, respectively. Accuracy was 60%, 97%, and 97%, respectively. There were no differences between SMI and CEUS in terms of sensitivity, specificity, or accuracy (100%, 93%, and 97%). We do not observe statistically significant differences between CTA, CEUS, and SMI concerning endoleak identification ability. The weakest method in endoleak identification was CDUS.
The analysis showed that SMI is effective, repeatable, and comparable with the CEUS modality in identification endoleaks after EVAR; it may be considered as a potential tool to monitor patients after EVAR implantation, especially those with renal insufficiency or with an allergy to any contrast media.
本研究旨在评估 Superb Micro-vascular Imaging(SMI)在血管内腹主动脉瘤修复(EVAR)后随访患者中替代对比增强超声(CEUS)和计算机断层血管造影(CTA)检测和分类内漏方面的有效性。
2015 年 5 月至 2017 年 1 月,30 例患者接受 EVAR 后彩色多普勒超声(CDUS)、CEUS、SMI 和 CTA 检查。评估了动脉瘤囊直径和移植物通畅性;确定并分类了内漏。计算了每种内漏检测四种诊断方法的敏感性、特异性和准确性值。计算了百分比一致性和 Cohen Kappa 系数,以比较各种方法在识别内漏方面的一致性。
CTA 显示 15 例内漏(50%):3 例 I 型 a,9 例 II 型,3 例 III 型。CDUS、CEUS 和 SMI 相对于 CTA 的敏感性分别为 27%、100%和 100%。特异性分别为 93%、93%和 93%。准确性分别为 60%、97%和 97%。SMI 与 CEUS 在敏感性、特异性或准确性(100%、93%和 97%)方面没有差异。我们没有观察到 CTA、CEUS 和 SMI 在识别内漏能力方面存在统计学差异。在识别内漏方面,最弱的方法是 CDUS。
分析表明,SMI 在 EVAR 后识别内漏方面是有效、可重复的,并且与 CEUS 模式相当;它可以被认为是监测 EVAR 植入后患者的潜在工具,尤其是那些肾功能不全或对任何造影剂过敏的患者。